OUR 9TH YEAR OF PROVIDING PROPRIETARY CAPITAL MARKETS INTELLIGENCE ON THE CANNABIS / HEMP / PSYCHEDELIC SECTORS
Quick
Links
Past Charts
Valuation Tracker By Industry Sector
Valuation Tracker By Sector
The Viridian Value Tracker is the most comprehensive valuation product in the industry.
-
- A broad set of 12 valuation measures assures applicability, regardless of whether the company has analyst coverage or revenues. The typically presented EV/ Projected Revenues and EV/ Projected EBITDA are available for less than 1/3 of the cannabis companies we track.
- Most valuation studies present only the average valuation measures, while the Tracker goes one step further and shows the distribution of values (the quartiles, median, and dispersion) for each measure. This gives users a more complete view of how companies in the cohort group are valued.
Week ended 08/02/2024
Weekly Sector Valuation Report – Cultivation & Retail Sector
- Although U.S. MSOs rallied strongly on Thursday, the median and third quartile market-to-book ratios for the group are now .38x and 1.29x, down from .43x and 1.41x, respectively, a week ago. The rally has no yet reversed the carnage from earlier in the week.
- Similarly, the median EV/ 2024 multiple of 6.15x is down from 6.36x last week and remains extremely low relative to past periods when legislative gains seemed imminent.
- Still, the positive comments from Trump regarding cannabis should mitigate at least one fundamental market fear: Trump does not appear likely to reverse the positive course of cannabis rescheduling and regulatory progress. The thesis of substantial gains upon greater visibility of S3 remains intact.
Week ended 08/02/2024
Weekly Sector Valuation Report – Cultivation & Retail Sector
- Although U.S. MSOs rallied strongly on Thursday, the median and third quartile market-to-book ratios for the group are now .38x and 1.29x, down from .43x and 1.41x, respectively, a week ago. The rally has no yet reversed the carnage from earlier in the week.
- Similarly, the median EV/ 2024 multiple of 6.15x is down from 6.36x last week and remains extremely low relative to past periods when legislative gains seemed imminent.
- Still, the positive comments from Trump regarding cannabis should mitigate at least one fundamental market fear: Trump does not appear likely to reverse the positive course of cannabis rescheduling and regulatory progress. The thesis of substantial gains upon greater visibility of S3 remains intact.
This Chart is Only Available to Higher Tier Memberships
Please Purchase a Premium or Enterprise membership to see more.
